3月31日上午10:30, 宝洁公司生物技术发展部全球总监Elena Lurieluke女士一行与北大科研部相关负责人访问6163am银河线路，并与6163am银河线路部分教师在英杰交流中心第一会议室进行了座谈。

 

               

 

    助理院长 唐少强">唐少强教授首先对客人的来访表示热烈的欢迎并向客人介绍了6163am银河线路的概况。Elena Lurieluke 也介绍了P&G的技术研发状况，说明此次来访主要关注于寻找具有自主知识产权、符合美国或欧洲安全管理标准的生物技术，主要包括植物提取物和中草药，微生物技术（天然防腐剂），表面活性剂技术，生物材料（包括纳米生物技术）等。

 

    6163am银河线路老师 韩平畴">韩平畴、 曹安源">曹安源、 陈海峰">陈海峰、 葛子钢">葛子钢、 侯仰龙">侯仰龙、 张珏">张珏、 陈正">陈正等参加了座谈会，并各自向客人介绍了的自己研究进展。宝洁公司作为世界上规模最大的日化消费品厂商，关注中国市场的发展，这和有着强大生物和医疗背景的6163am银河线路有着共同的目标，双方均表示今后将利用各自的优势在科研方面展开更加广泛的合作。

 

    会后，6163am银河线路院长 陈十一">陈十一会见了Elena Lurieluke女士一行并出席了招待午宴。

 

Elena Lurieluke 女士简历及P&G Bioscience简介：

 

Elena Lurie-Luke, Procter & Gamble

 

Elena is Director of Global Bioscience Business Development and based in Egham, UK.  She has been with P&G for 13 years and has moved to her current role three years ago. Before that she has worked in HealthCare Division where she had a wide range of experience including GMP audits of non western suppliers, global product design and professional credentialing.

 

Elena was born in Russia and has degrees in Chemical Engineering and Biotechnology, and PhD in Biochemistry from M.V Lomonsov Moscow State Academy of Fine Chemical Technology. Before joining P&G she worked as an Assistant Professor at the Biotechnology Department (M.V Lomonsov Moscow State Academy of Fine Chemical Technology) and then a post doctoral scientist in department of Surgery, Northwick Park Institute For Medical Research.  In addition to her biochemistry degrees, Elena’s work with healthcare professional in Western Europe as well as her presentations and publications in healthcare peer reviewed journals enabled her to become a Fellow of the Royal Society of Medicine.

 

Her current responsibilities are with P&G Connect & Develop programme that involve identifying best-in-class solutions/opportunities elsewhere and bringing them into P&G.  

 

P&G Bioscience

 

The Procter & Gamble Company is the world's largest consumer products company (global sales of approx $83 Billion USD [NYSE: PG]). The company's mission is to improve the lives of the world's consumers. The Corporate Bioscience Business Development Division is seeking bioscience related technologies and opportunities to improve the performance and benefits of all of P&G's portfolio of products and make them more even more competitive in the marketplace.  Product focus areas range from skin and hair health and beauty, to traditional OTC health care, female uro-genital health, pet (dog and cat) health, microbiology to better ways to clean non-biological and biological surfaces.  Technologies of interest range from approaches that elicit beneficial biological responses in consumers (bioactives) to technologies that could be used in product formulation (e.g., biopolymers) and analytical testing. Specifically, We look for technologies that could be used in skin and hair care products. We are only interested in approaches that can be developed as non-Rx products and technologies.